Frontlight ResearchEarly access
Taking people in Hong KongNo phase
Screening people with HIV and hepatitis B for hepatitis delta virus
Checks adults with HIV, hepatitis B and liver cancer for hepatitis delta virus.
Key facts
- Who runs it
- Grace Lai Hung Wong
- Where
- Hong Kong, Hong KongSee the site
- Trial code
- Registry title
- HDV Screening Study
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 15 Feb 2025
- Expected to end
- 17 Feb 2029
- Type of study
- Observational
- Record updated
- 24 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults living with both HIV and long-term hepatitis B. It tests them for hepatitis delta virus (HDV).
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Chronic hepatitis B: HBsAg or HBV DNA positive two times, at least 6 months apart
- Biomarker or test result
- HIV infection: anti-HIV or HIV RNA positive. Chronic hepatitis B: HBsAg or HBV DNA positive.
Main reasons for not taking part
- Refusal to give consent
- Age under 18 years
This trial only enrols participants living with HIV. The registry sentence this rests on: 1. Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Individuals with HIV infection, i.e. anti-HIV or HIV RNA positive; AND
- Individuals with chronic hepatitis B, i.e. hepatitis B surface antigen (HBsAg) or HBV DNA positive for two times at least 6 months apart; AND
- Aged 18 years old or above
- Written or verbal consent obtained
Who cannot take part
- Age < 18 years
- Refusal to consent
Where in Hong Kong
- The Chinese University of Hong KongHong Kong, Hong KongContact: Angel ChimTaking people
About the trial
What the trial wants to find out
This is a territory-wide cross-sectional study of all individuals living with HIV/HBV coinfection and HBV-related HCC.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Universal Screening for Hepatitis Delta Virus (HDV) in Individuals Living with HIV/HBV Coinfection and HBV-related HCC
- Plain-language title
- Screening people with HIV and hepatitis B for hepatitis delta virusGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 24 March 2025